T-CELL RESPONSES AND VIRUS EVOLUTION - LOSS OF HLA A11-RESTRICTED CTL EPITOPES IN EPSTEIN-BARR-VIRUS ISOLATES FROM HIGHLY A11-POSITIVE POPULATIONS BY SELECTIVE MUTATION OF ANCHOR RESIDUES

被引:145
作者
DECAMPOSLIMA, PO
LEVITSKY, V
BROOKS, J
LEE, SP
HU, LF
DICKINSON, AB
MASUCCI, MG
机构
[1] KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,TUMOR BIOL LAB,BOX 60400,S-17771 STOCKHOLM,SWEDEN
[2] UNIV BIRMINGHAM,DEPT CANC STUDIES,CANC RES CAMPAIGN LABS,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND
关键词
D O I
10.1084/jem.179.4.1297
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV) is a B lymphotropic herpesvirus of humans that elicits strong HLA class I-restricted cytotoxic T lymphocyte (CTL) responses. An influence of such responses on virus evolution was first suggested by our finding that EBV isolates from the highly HLA A11-positive Papua New Guinea (PNG) population carried a lys-thr mutation at residue 424 of the nuclear antigen EBV-encoded nuclear antigen (EBNA4) that destroyed the immunodominant target epitope for A11-restricted CTL recognition. Here we turn to a much larger population, Southern Chinese, where the All allele is again present in over 50% of the individuals. Each of 23 EBV isolates analyzed from this population were also mutated in the EBNA4 416-424 epitope, the mutations selectively involving one of the two anchor residues in positions 2 (417 val-leu) or 9 (424 lys-asp, -arg or -thr) that are critical for All-peptide interaction. The majority of the Chinese isolates and all 10 PNG isolates also carried mutations affecting positions 1 and 2 of the next most immunodominant A11-restricted epitope, EBNA4 residues 399-408. These changes dearly affected antigenicity since A11-positive lymphoblastoid cell lines (LCLs) carrying these mutant EBV strains were not recognized by A11-restricted CTLs raised against the prototype B95.8 virus. Furthermore, Chinese donors naturally infected with these mutant viruses did not mount detectable A11-restricted CTL responses on in vitro stimulation with autologous LCL cells carrying either the B95.8 or their endogenous EBV strain. In two different highly A11-positive populations, therefore, immune pressure appears to have selected for resident EBV strains lacking immunodominant A11-restricted CTL epitopes.
引用
收藏
页码:1297 / 1305
页数:9
相关论文
共 30 条
[1]  
ALLSOPP CEM, 1992, AM J HUM GENET, V50, P411
[2]   DIFFERENT HLA-B27 SUBTYPES PRESENT THE SAME IMMUNODOMINANT EPSTEIN-BARR-VIRUS PEPTIDE [J].
BROOKS, JM ;
MURRAY, RJ ;
THOMAS, WA ;
KURILLA, MG ;
RICKINSON, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :879-887
[3]   AN EPSTEIN-BARR VIRUS-SPECIFIC CYTOTOXIC T-CELL EPITOPE PRESENT ON A-TYPE AND B-TYPE TRANSFORMANTS [J].
BURROWS, SR ;
MISKO, IS ;
SCULLEY, TB ;
SCHMIDT, C ;
MOSS, DJ .
JOURNAL OF VIROLOGY, 1990, 64 (08) :3974-3976
[4]   AN EPSTEIN-BARR VIRUS-SPECIFIC CYTOTOXIC T-CELL EPITOPE IN EBV NUCLEAR ANTIGEN-3 (EBNA-3) [J].
BURROWS, SR ;
SCULLEY, TB ;
MISKO, IS ;
SCHMIDT, C ;
MOSS, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :345-349
[5]   HLA-A11 EPITOPE LOSS ISOLATES OF EPSTEIN-BARR-VIRUS FROM A HIGHLY A11+ POPULATION [J].
DECAMPOSLIMA, PO ;
GAVIOLI, R ;
ZHANG, QJ ;
WALLACE, LE ;
DOLCETTI, R ;
ROWE, M ;
RICKINSON, AB ;
MASUCCI, MG .
SCIENCE, 1993, 260 (5104) :98-100
[6]  
DUMAS B, 1975, CLIN CHEM, V21, P1159
[7]   RECOGNITION OF THE EPSTEIN-BARR VIRUS-ENCODED NUCLEAR ANTIGENS EBNA-4 AND EBNA-6 BY HLA-A11-RESTRICTED CYTOTOXIC LYMPHOCYTES-T - IMPLICATIONS FOR DOWN-REGULATION OF HLA-A11 IN BURKITT-LYMPHOMA [J].
GAVIOLI, R ;
DECAMPOSLIMA, PO ;
KURILLA, MG ;
KIEFF, E ;
KLEIN, G ;
MASUCCI, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :5862-5866
[8]   MULTIPLE HLA A11-RESTRICTED CYTOTOXIC LYMPHOCYTE-T EPITOPES OF DIFFERENT IMMUNOGENICITIES IN THE EPSTEIN-BARR VIRUS-ENCODED NUCLEAR ANTIGEN-4 [J].
GAVIOLI, R ;
KURILLA, MG ;
DECAMPOSLIMA, PO ;
WALLACE, LE ;
DOLCETTI, R ;
MURRAY, RJ ;
RICKINSON, AB ;
MASUCCI, MG .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1572-1578
[9]  
GOTCH FM, 1986, J EXP MED, V165, P408
[10]  
HIRS C, 1977, ENZYME STRUCTURE, V47, P501